iAnthus Capital Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was USD 35.39 million compared to USD 40.29 million a year ago. Net loss was USD 12.55 million compared to USD 11.64 million a year ago.
For the nine months, sales was USD 108.7 million compared to USD 124.85 million a year ago. Net loss was USD 26.11 million compared to USD 35.43 million a year ago.
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.
